Resistance-Sensing Needle Identifies Target Destinations
By HospiMedica International staff writers Posted on 18 Mar 2019 |
Image: An intelligent needle can identify minute voids for injection (Photo courtesy of Randal McKenzie/ HMS).
A highly sensitive intelligent-injector for tissue-targeting (i2T2) needle can detect changes in resistance in order to properly and safely deliver medication, claims a new study.
Developed by researchers at the Massachusetts Institute of Technology (MIT, Cambridge, MA, USA), Harvard Medical School (HMS; Boston, MA, USA), and Brigham and Women’s Hospital (BWH; Boston, MA, USA), the i2T2 intelligent injector is a highly sensitive, completely mechanical device that senses loss of tissue resistance when encountering a softer tissue or a cavity, causing it to stop advancing the needle and deliver the payload. i2T2 feedback is instantaneous, which allows for better tissue targeting and minimal overshoot into an undesired location.
To test the device, the researchers used tissue from three animal models to examine delivery accuracy in the suprachoroidal (SCS), epidural, and peritoneal spaces, as well as subcutaneously. For example, they found it can be used to reliably deliver liquids to the SCS for a wide range of eye sizes, scleral thicknesses, and intraocular pressures. The injector could also deliver stem cells to the back of the eye that could be useful for regenerative therapies. The study was published on February 25, 2019, in Nature Biomedical Engineering.
“Targeting specific tissues using a conventional needle can be difficult, and often requires a highly trained individual. In the past century there has been minimal innovation to the needle itself, and we saw this as an opportunity to develop better, more accurate devices,” said senior corresponding author Professor Jeff Karp, PhD, of Brigham and Women’s Hospital. “We sought to achieve improved tissue targeting while keeping the design as simple as possible for ease of use.”
The SCS, which is located between the sclera and choroid in the back of the eye, has emerged as an important location for medication delivery. It is also a challenging site to target, because the needle must stop after transitioning through the sclera, which is less than one millimeter thick, to avoid damaging the retina. Additional tissues that are difficult to target include the epidural space around the spinal cord, used for epidural anesthesia, the peritoneal space in the abdomen, and subcutaneous tissue between the skin and muscles.
Related Links:
Massachusetts Institute of Technology
Harvard Medical School
Brigham and Women’s Hospital
Developed by researchers at the Massachusetts Institute of Technology (MIT, Cambridge, MA, USA), Harvard Medical School (HMS; Boston, MA, USA), and Brigham and Women’s Hospital (BWH; Boston, MA, USA), the i2T2 intelligent injector is a highly sensitive, completely mechanical device that senses loss of tissue resistance when encountering a softer tissue or a cavity, causing it to stop advancing the needle and deliver the payload. i2T2 feedback is instantaneous, which allows for better tissue targeting and minimal overshoot into an undesired location.
To test the device, the researchers used tissue from three animal models to examine delivery accuracy in the suprachoroidal (SCS), epidural, and peritoneal spaces, as well as subcutaneously. For example, they found it can be used to reliably deliver liquids to the SCS for a wide range of eye sizes, scleral thicknesses, and intraocular pressures. The injector could also deliver stem cells to the back of the eye that could be useful for regenerative therapies. The study was published on February 25, 2019, in Nature Biomedical Engineering.
“Targeting specific tissues using a conventional needle can be difficult, and often requires a highly trained individual. In the past century there has been minimal innovation to the needle itself, and we saw this as an opportunity to develop better, more accurate devices,” said senior corresponding author Professor Jeff Karp, PhD, of Brigham and Women’s Hospital. “We sought to achieve improved tissue targeting while keeping the design as simple as possible for ease of use.”
The SCS, which is located between the sclera and choroid in the back of the eye, has emerged as an important location for medication delivery. It is also a challenging site to target, because the needle must stop after transitioning through the sclera, which is less than one millimeter thick, to avoid damaging the retina. Additional tissues that are difficult to target include the epidural space around the spinal cord, used for epidural anesthesia, the peritoneal space in the abdomen, and subcutaneous tissue between the skin and muscles.
Related Links:
Massachusetts Institute of Technology
Harvard Medical School
Brigham and Women’s Hospital
Latest Surgical Techniques News
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery
- Robotic Nerve ‘Cuffs’ Could Treat Various Neurological Conditions
- Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons
- Next-Gen Computer Assisted Vacuum Thrombectomy Technology Rapidly Removes Blood Clots
- Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices
- Custom 3D-Printed Orthopedic Implants Transform Joint Replacement Surgery
- Wearable Technology Monitors and Analyzes Surgeons' Posture during Long Surgical Procedures
- Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery
- Computational Models Predict Heart Valve Leakage in Children
- Breakthrough Device Enables Clear and Real-Time Visual Guidance for Effective Cardiovascular Interventions
- World’s First Microscopic Probe to Revolutionize Early Cancer Diagnosis
- World’s Smallest Implantable Brain Stimulator Demonstrated in Human Patient
- Robotically Assisted Lung Transplants Could Soon Become a Reality
- AI to Provide Heart Transplant Surgeons with New Decision-Making Data
- New Surgical Tool Empowers Precision and Confidence in Operating Room